N-MYC regulation of DNA damage response in neuroendocrine prostate cancer: mechanistic insight and novel combination therapy approaches

Oncoscience. 2018 Aug 22;5(11-12):273-275. doi: 10.18632/oncoscience.462. eCollection 2018 Nov.

Authors

Timothy C Thompson¹, Bo Liu¹, Likun Li¹

Affiliation

¹ Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

No abstract available

Keywords: Combination therapy; DNA damage response; N-MYC; PARP inhibitors; neuroendocrine prostate cancer.

Grants and funding